Elongase Reactions as Control Points in Long-Chain Polyunsaturated Fatty Acid Synthesis
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Δ6-Desaturase (Fads2) is widely regarded as rate-limiting in the conversion of dietary α-linolenic acid (18:3n-3; ALA) to the long-chain omega-3 polyunsaturated fatty acid docosahexaenoic acid (22:6n-3; DHA). However, increasing dietary ALA or the direct Fads2 product, stearidonic acid (18:4n-3; SDA), increases tissue levels of eicosapentaenoic acid (20:5n-3; EPA) and docosapentaenoic acid (22:5n-3; DPA), but not DHA. These observations suggest that one or more control points must exist beyond ALA metabolism by Fads2. One possible control point is a second reaction involving Fads2 itself, since this enzyme catalyses desaturation of 24:5n-3 to 24:6n-3, as well as ALA to SDA. However, metabolism of EPA and DPA both require elongation reactions. This study examined the activities of two elongase enzymes as well as the second reaction of Fads2 in order to concentrate on the metabolism of EPA to DHA. METHODOLOGY/PRINCIPAL FINDINGS: The substrate selectivities, competitive substrate interactions and dose response curves of the rat elongases, Elovl2 and Elovl5 were determined after expression of the enzymes in yeast. The competitive substrate interactions for rat Fads2 were also examined. Rat Elovl2 was active with C(20) and C(22) polyunsaturated fatty acids and this single enzyme catalysed the sequential elongation reactions of EPA→DPA→24:5n-3. The second reaction DPA→24:5n-3 appeared to be saturated at substrate concentrations not saturating for the first reaction EPA→DPA. ALA dose-dependently inhibited Fads2 conversion of 24:5n-3 to 24:6n-3. CONCLUSIONS: The competition between ALA and 24:5n-3 for Fads2 may explain the decrease in DHA levels observed after certain intakes of dietary ALA have been exceeded. In addition, the apparent saturation of the second Elovl2 reaction, DPA→24:5n-3, provides further explanations for the accumulation of DPA when ALA, SDA or EPA is provided in the diet. This study suggests that Elovl2 will be critical in understanding if DHA synthesis can be increased by dietary means.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Fgure 1. Comparison of the rat Elovl5 and Elovl2 substrate specificities. Recombinant S. cerevisiae expressing Elovl5 (A) or Elovl2 (B) were grown in the presence of 100 µM of various C18, C20 and C22 PUFA substrates. Fatty acids were extracted from the recombinant S. cerevisiae and the amount of each fatty acid was expressed as a percentage of the total amount of all fatty acids. The proportion of substrate fatty acid converted to longer chain fatty acid product(s) was calculated as [product(s)/(product(s) + substrate)]×100. The product was 2 carbons longer than the substrate. § denotes that the conversion includes the 4 carbon elongation product. The results are the means ± S.D. of triplicate incubations. Values with different symbols are significantly different from each other. ND, not detected.](https://figures.cochat.ai/paper-figures/160a365940d74b83997ce7d69c7a7ee5/elongase-reactions-as-control-points-in-long-chain-polyunsaturated-fatty-acid-figure-1.jpg)
![Figure 2 Competition between n-3 PUFA substrates for elongation by Elovl5. Recombinant S. cerevisiae expressing Elovl5 were grown in the presence of 100 µM of SDA and 0–300 µM EPA (A) or 100 µM of EPA and 0–300 µM SDA (B). Recombinant S. cerevisiae containing the empty pYES2 vector were grown in the presence of 0–300 µM EPA or SDA. Fatty acids were extracted from the recombinant S. cerevisiae and the amount of each fatty acid was quantified in µg g−1 of S. cerevisiae or expressed as a percentage of the total amount of all fatty acids. The proportion of substrate fatty acid converted to longer chain fatty acid product(s) was calculated as [product(s)/(product(s) + substrate)]×100. The conversion of SDA includes the 4 carbon elongation product 22:4n-3. The results are the means ± S.D. of triplicate incubations. Values with different symbols are significantly different from each other.](https://figures.cochat.ai/paper-figures/ac71d19d1d1344839128db60cfffbc91/elongase-reactions-as-control-points-in-long-chain-polyunsaturated-fatty-acid-figure-2.jpg)


![Figure 5 The rat Fads2 substrate specificity. Recombinant S. cerevisiae expressing Fads2 were grown in the presence of 100 µM of various PUFA substrates. Fatty acids were extracted from the recombinant S. cerevisiae and the amount of each fatty acid was expressed as a percentage of the total amount of all fatty acids. The proportion of substrate fatty acid converted to desaturation product was calculated as [product/(product + substrate)]×100. The product contained one more double bond than the substrate. The results are the means ± S.D. of triplicate incubations. Values with different symbols are significantly different from each other.](https://figures.cochat.ai/paper-figures/ccf68986a29d4ddb985fd1ba0f783595/elongase-reactions-as-control-points-in-long-chain-polyunsaturated-fatty-acid-figure-5.jpg)

![Figure 7 Competition between n-3 PUFA substrates for desaturation by Fads2. Recombinant S. cerevisiae expressing Fads2 were grown in the presence of 25 µM of 24:5n-3 and 0–400 µM ALA. Fatty acids were extracted from the recombinant S. cerevisiae and the amount of each fatty acid was expressed as a percentage of the total amount of all fatty acids. The proportion of substrate fatty acid converted to desaturation product was calculated as [product/(product + substrate)]×100. The results are the means ± S.D. of triplicate incubations. Values with different symbols are significantly different from each other.](https://figures.cochat.ai/paper-figures/d24c57ed7c414ce2ac9eff6035174e83/elongase-reactions-as-control-points-in-long-chain-polyunsaturated-fatty-acid-figure-7.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is now also known that DPA also produces analogous inflammatory mediators to EPA and DHA, and elongation of EPA to DPA may be an important event in the inhibition of the COX pathway [52,146].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [146]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fatty acid elongases in mammals: their regulation and roles in metabolism
JAKOBSSON, A., WESTERBERG, R., & JACOBSSON, A. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.01.004 · Cited by 936
Cloning, Expression, and Nutritional Regulation of the Mammalian Δ-6 Desaturase
Cho, H. P., Nakamura, M. T., & Clarke, S. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.471 · Cited by 628
James, M. J., Ursin, V. M., & Cleland, L. G. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1140 · Cited by 354
Self-citationMorais, S., Monroig, O., Zheng, X., Leaver, M. J., & Tocher, D. R. (2009) · Marine Biotechnology · doi:10.1007/s10126-009-9179-0 · Cited by 244
Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice
Moon, Y.-A., Hammer, R. E., & Horton, J. D. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800383-jlr200 · Cited by 236
Molecular Cloning and Functional Characterization of Rat Δ-6 Fatty Acid Desaturase
Aki, T., Shimada, Y., Inagaki, K., Higashimoto, H., Kawamoto, S., Shigeta, S., Ono, K., & Suzuki, O. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0235 · Cited by 230
Δ6‐Desaturase (FADS2) deficiency unveils the role of ω3‐ and ω6‐polyunsaturated fatty acids
Stoffel, W., Holz, B., Jenke, B., Binczek, E., Günter, R. H., Kiss, C., Karakesisoglou, I., Thevis, M., Weber, A., Arnhold, S., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.156 · Cited by 230
Leonard, A. E., BOBIK, E. G., DORADO, J., Kroeger, P. E., Chuang, L., Thurmond, J. M., PARKER-BARNES, J. M., Das, T., Huang, Y. S., & Mukerji, P. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3500765 · Cited by 220
Park, W. J., Kothapalli, K. S. D., Lawrence, P., Tyburczy, C., & Brenna, J. T. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800630-jlr200 · Cited by 218
Identification and expression of mammalian long‐chain PUFA elongation enzymes
Leonard, A. E., Kelder, B., Bobik, E. G., Chuang, L., Lewis, C. J., Kopchick, J. J., Mukerji, P., & Huang, Y. (2002) · Lipids · doi:10.1007/s11745-002-0955-6 · Cited by 209 · cited 7×
“through to 24:5n-3 with less accumulation of DPA [6].”
BackgroundResultInfluential
Cited by
Dyall, S. C. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00052 · Cited by 943
Metabolism and functional effects of plant-derived omega-3 fatty acids in humans
Baker, E. J., Miles, E. A., Burdge, G. C., Yaqoob, P., & Calder, P. C. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.07.002 · Cited by 472
Castro, L. F. C., Tocher, D. R., & Monroig, O. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.01.001 · Cited by 450
The gut microbiota promotes hepatic fatty acid desaturation and elongation in mice
Kindt, A., Liebisch, G., Clavel, T., Haller, D., Hörmannsperger, G., Yoon, H., Kolmeder, D., Sigruener, A., Krautbauer, S., Seeliger, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05767-4 · Cited by 311
Fatty acids in cardiovascular health and disease: A comprehensive update
Baum, S. J., Kris-Etherton, P. M., Willett, W. C., Lichtenstein, A. H., Rudel, L. L., Maki, K. C., Whelan, J., Ramsden, C. E., & Block, R. C. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.04.077 · Cited by 277
Metadata
- Authors
- Gregory, M. K., Gibson, R. A., Cook-Johnson, R. J., Cleland, L. G., & James, M. J.
- Affiliations
- Royal Adelaide Hospital (AU)
- The University of Adelaide (AU)
- Corresponding author
- Gregory, Melissa K.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-12-22
- Volume
- 6
- Issue
- 12
- Pages
- e29662
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3245304
- OpenAlex
- W2160923256
- Cited by
- 192
- References
- 24
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 12 · 2023: 12 · 2022: 9 · 2021: 17 · 2020: 14 · 2019: 13 · 2018: 20 · 2017: 10 · 2016: 16 · 2015: 14 · 2014: 15 · 2013: 13 · 2012: 10
- FWCI
- 11.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Medical Research Council
- Australian Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
- Keywords
- delta-6 desaturase, FADS2, ELOVL2, ELOVL5, omega-3 fatty acids, docosahexaenoic acid, eicosapentaenoic acid, docosapentaenoic acid, stearidonic acid, alpha-linolenic acid, substrate specificity, enzyme saturation
- MeSH terms
- Fatty Acid Elongases, Acetyltransferases, Animals, Fatty Acids, Unsaturated, Humans, Substrate Specificity, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elongase Reactions as Control Points in Long-Chain Polyunsaturated Fatty Acid Synthesis. https://app.cochat.ai/papers/10.1371/journal.pone.0029662
- The paper
- Gregory, M. K., Gibson, R. A., Cook-Johnson, R. J., Cleland, L. G., & James, M. J. (2011). Elongase Reactions as Control Points in Long-Chain Polyunsaturated Fatty Acid Synthesis. PLoS ONE. https://doi.org/10.1371/journal.pone.0029662
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.